Novozithron (Azithromycin)

Azithromycin acts by binding to the 50S subunit of bacterial ribosomes, inhibiting the translocation step of protein synthesis. This blocks the formation of new proteins, resulting in a bacteriostatic effect that stops bacterial growth and allows the immune system to clear the infection.

The dosage of Novozithron is determined by the prescribing clinician based on the specific infection, patient age, weight, renal and hepatic function, and local treatment guidelines. Healthcare providers select the appropriate regimen and duration for each individual case.

Azithromycin is classified as Pregnancy Category B in many regions, indicating that animal studies have not shown risk but there are limited human data. It should be used during pregnancy or lactation only when the potential benefit justifies any possible risk to the fetus or infant.

To place an order, submit an enquiry on the Novozithron product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Novozithron (azithromycin) belongs to the macrolide class, which offers a long half‑life and high tissue penetration compared with other antibiotics such as doxycycline or fluoroquinolones. It is often preferred for patients needing once‑daily dosing and for infections caused by atypical organisms, though resistance patterns and individual patient factors guide the final choice.

Novozithron tablets should be stored at room temperature, below 25 °C, in the original container to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Novozithron is supplied as oral tablets and is taken by mouth, with or without food, as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious adverse events include QT interval prolongation leading to potentially life‑threatening arrhythmias, severe allergic reactions such as anaphylaxis, hepatic dysfunction manifested by elevated liver enzymes or jaundice, and Clostridioides difficile‑associated colitis. Patients should seek immediate medical attention if they experience chest pain, palpitations, rash, swelling, or persistent diarrhea.

Novozithron should be avoided in individuals with a known hypersensitivity to azithromycin or other macrolide antibiotics, patients with a history of significant QT prolongation or ventricular arrhythmias, and those taking medications that strongly interact to increase cardiac risk. Caution is also advised for patients with severe hepatic impairment.